Yifan Pharmaceutical Co., Ltd. (SHE:002019)
12.10
+0.61 (5.31%)
May 13, 2025, 3:04 PM CST
Yifan Pharmaceutical Revenue
Yifan Pharmaceutical had revenue of 1.33B CNY in the quarter ending March 31, 2025, with 0.05% growth. This brings the company's revenue in the last twelve months to 5.16B, up 15.82% year-over-year. In the year 2024, Yifan Pharmaceutical had annual revenue of 5.16B with 26.84% growth.
Revenue (ttm)
5.16B
Revenue Growth
+15.82%
P/S Ratio
2.85
Revenue / Employee
1.26M
Employees
4,098
Market Cap
14.72B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.16B | 1.09B | 26.84% |
Dec 31, 2023 | 4.07B | 231.47M | 6.03% |
Jan 1, 2023 | 3.84B | -572.39M | -12.98% |
Jan 1, 2022 | 4.41B | -991.34M | -18.36% |
Dec 31, 2020 | 5.40B | 213.54M | 4.12% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |